The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GL ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
Hims & Hers Health, Inc. (NYSE:HIMS) 首席商务官Michael Chi于2024年11月25日报告出售了17,303股公司A类普通股。这些股票以平均价格26.49美元出售,交易总额约为458,356美元。
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...